Palvella Therapeutics Inc. (PVLA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Palvella Therapeutics Inc...

    NASDAQ: PVLA · Real-Time Price · USD
    65.78
    3.15 (5.03%)
    At close: Oct 03, 2025, 3:59 PM
    65.91
    0.20%
    After-hours: Oct 03, 2025, 07:44 PM EDT

    Palvella Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -17.43M 18.69M -27.55M -45.74M
    Depreciation & Amortization
    		 n/a n/a n/a 2.37M
    Stock-Based Compensation
    		 830K 603K 427K n/a
    Other Working Capital
    		 -453K -904K -359K 25.29M
    Other Non-Cash Items
    		 5.96M -29.85M 10.66M 5.18M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -193K -3.15M 1.62M 30.52M
    Operating Cash Flow
    		 -10.84M -13.7M -14.84M -7.66M
    Capital Expenditures
    		 n/a n/a -1.04M -949K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a -48.4M n/a
    Sales Maturities Of Investments
    		 n/a n/a 28.2M n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a -21.24M -949K
    Debt Repayment
    		 78.43M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 8.65M 5M 34K n/a
    Financial Cash Flow
    		 87.09M 5M 9.57M 59.13M
    Net Cash Flow
    		 76.25M -8.7M -5.27M 47.33M
    Free Cash Flow
    		 -10.84M -13.7M -14.84M -8.61M

    Add to Watchlist